Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BBOX1 | O75936 | 2/20 | 0.68 |
| ▸ | HTT | P42858 | 2/20 | 0.60 |
| ▸ | DNM1 | Q05193 | 8/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.48 |
| ▸ | RAD52 | P43351 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10933662 | 1.00 | BBOX1 (0.68) | BBOX1HTTDNM1KMT2AHSP90AA1 | |
| SCHEMBL61438 | 1.00 | BBOX1 (0.68) | BBOX1HTTDNM1KMT2AHSP90AA1 | |
| SCHEMBL61124 | 1.00 | BBOX1 (0.68) | BBOX1HTTDNM1KMT2AHSP90AA1 | |
| SCHEMBL10936179 | 1.00 | BBOX1 (0.68) | BBOX1HTTDNM1KMT2AHSP90AA1 | |
| SCHEMBL10937740 | 1.00 | BBOX1 (0.68) | BBOX1HTTDNM1KMT2AHSP90AA1 | |
| SCHEMBL9691206 | 1.00 | BBOX1 (0.68) | BBOX1HTTDNM1KMT2AHSP90AA1 | |
| SCHEMBL61271 | 1.00 | BBOX1 (0.68) | BBOX1HTTDNM1KMT2AHSP90AA1 | |
| SCHEMBL10975952 | 1.00 | BBOX1 (0.68) | BBOX1HTTDNM1KMT2AHSP90AA1 | |
| SCHEMBL60617 | 1.00 | BBOX1 (0.68) | BBOX1HTTDNM1KMT2AHSP90AA1 | |
| SCHEMBL62048 | 1.00 | BBOX1 (0.68) | BBOX1HTTDNM1KMT2AHSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 978 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12525409-B2 | Wide voltage window aqueous electrolyte solution for forming SEI film based on physical process, and preparation method and use thereof | ZHEJIANG UNIVERSITY (CN) | 2026-01-13 | — | — | US | claimed |
| US-20250388896-A1 | COMPOSITION AND METHODS FOR TRANSGENE INSERTION | CELYNTRA THERAPEUTICS SA (BE) | 2025-12-25 | — | — | US | claimed |
| US-20250320406-A1 | QUANTUM DOT MATERIAL, METHOD FOR PREPARING THE SAME, AND QUANTUM DOT FILM AND BACKLIGHT MODULE USING THE SAME | FOXCONN TECH CO LTD (TW) | 2025-10-16 | — | — | US | claimed |
| US-20250259801-A1 | WIDE VOLTAGE WINDOW AQUEOUS ELECTROLYTE SOLUTION FOR FORMING SEI FILM BASED ON PHYSICAL PROCESS, AND PREPARATION METHOD AND USE THEREOF | ZHEJIANG UNIVERSITY | 2025-08-14 | — | — | US | claimed |
| EP-4560307-A2 | METHOD, SOLUTION AND KIT FOR PREPARING A TISSUE SAMPLE FOR 3D IMAGING | The Francis Crick Institute Limited (GB) | 2025-05-28 | — | — | EP | claimed |
| CN-119897071-A | Sulfobetaine-modified montmorillonite composite material and preparation method and application thereof | 湖南大学 | 2025-04-29 | — | — | CN | claimed |
| CN-116626283-B | Kit for auxiliary diagnosis of interstitial lung diseases by KL-6 protein on exosome and application | 广州医科大学附属第一医院（广州呼吸中心） | 2025-04-01 | — | — | CN | claimed |
| EP-4486881-A1 | COMPOSITION AND METHODS FOR TRANSGENE INSERTION | Celyntra Therapeutics SA (BE) | 2025-01-08 | — | — | EP | claimed |
| EP-3881050-B1 | METHOD, SOLUTION AND KIT FOR PREPARING A TISSUE SAMPLE FOR 3D IMAGING | THE FRANCIS CRICK INSTITUTE LTD (GB) | 2025-01-01 | — | — | EP | claimed |
| US-20240426841-A1 | KIT OF KL-6 PROTEIN ON EXOSOMES FOR AUXILIARY DIAGNOSIS OF INTERSTITIAL LUNG DISEASE AND USE THEREOF | Guangzhou Institute of respiratory health (Guangzhou Institute of respiratory diseases) (CN) | 2024-12-26 | — | — | US | claimed |
| US-20020137060-A1 | Combined hybridization-detection assays for determining nucleic acid concentrations in biological fluids | BROWN-AUGSBURGER PATRICIA LEA (US) | 2002-09-26 | — | — | US | claimed |
| US-5932428-A | Method for preparing a sample in a scan capillary for immunofluorescent interrogation | BIOMETRIC IMAGING, INC. (US) | 1999-08-03 | — | — | US | claimed |
| EP-0788604-A4 | METHOD FOR PREPARING A SAMPLE IN A SCAN CAPILLARY FOR IMMUNOFLUORESCENT INTERROGATION | BIOMETRIC IMAGING INC (US) | 1998-12-30 | — | — | EP | claimed |
| EP-0788604-A1 | METHOD FOR PREPARING A SAMPLE IN A SCAN CAPILLARY FOR IMMUNOFLUORESCENT INTERROGATION | BIOMETRIC IMAGING, INC. (US) | 1997-08-13 | — | — | EP | claimed |
| US-5585246-A | Method for preparing a sample in a scan capillary for immunofluorescent interrogation | BIOMETRIC IMAGING, INC. (US) | 1996-12-17 | — | — | US | claimed |
| WO-1996012963-A1 | METHOD FOR PREPARING A SAMPLE IN A SCAN CAPILLARY FOR IMMUNOFLUORESCENT INTERROGATION | BIOMETRIC IMAGING, INC. (US) | 1996-05-02 | — | — | WO | claimed |
| EP-0188450-B1 | METHODS FOR THE IN VITRO DETECTION AND IDENTIFICATION OF UNKNOWN PATHOGENS OR GENETIC ENTITIES | DIAGNOSTIC RESEARCH LIMITED PARTNERSHIP (US) | 1992-08-12 | — | — | EP | claimed |
| EP-0471293-A2 | Solubilization reagent for biological test samples | ABBOTT LABORATORIES (US) | 1992-02-19 | — | — | EP | claimed |
| EP-0308239-A2 | Method for reducing bacterial endotoxin contamination in solutions of macromolecules | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1989-03-22 | — | — | EP | claimed |
| US-4808314-A | MIXING WITH SURFACTANT, ABSORPTION, SEPARATION | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1989-02-28 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250388896-A1 | COMPOSITION AND METHODS FOR TRANSGENE INSERTION | GDA, XPA, ERCC2 | BBOX1 3065/4885HTT 190/4885DNM1 2445/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.